Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 10/20 | 0.58 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.58 |
| ▸ | MAOB | P27338 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | CACNA1B | Q00975 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL737246 | 0.83 | HRH3 (0.67) | HRH3KCNH2MAOBCACNA1BALDH1A1 | |
| SCHEMBL737616 | 0.80 | HRH3 (0.58) | HRH3KCNH2MAOBMAPTPOLB | |
| Trifluoroacetic Acid SCHEMBL735635 | 0.79 | HRH3 (0.57) | HRH3KCNH2MAPTPOLBCACNA1B | |
| Trifluoroacetic Acid SCHEMBL3573078 | 0.78 | HRH1 (0.58) | HRH3KCNH2MAPTALDH1A1GAA | |
| Trifluoroacetic Acid SCHEMBL738381 | 0.77 | HRH3 (0.61) | HRH3KCNH2ALDH1A1MEN1KMT2A | |
| Trifluoroacetic Acid SCHEMBL736519 | 0.77 | HRH3 (0.55) | HRH3KCNH2MAPTPOLBCACNA1B | |
| Trifluoroacetic Acid SCHEMBL737443 | 0.77 | HRH3 (0.60) | HRH3KCNH2MAPTPOLBCACNA1B | |
| SCHEMBL6472573 | 0.76 | HRH3 (0.72) | HRH3KCNH2MAPTPOLBALDH1A1 | |
| Trifluoroacetic Acid SCHEMBL738424 | 0.75 | HRH3 (0.52) | HRH3KCNH2CACNA1BALDH1A1GAA | |
| Trifluoroacetic Acid SCHEMBL3576594 | 0.75 | HRH3 (0.53) | HRH3KCNH2MAPTCACNA1BALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090137576-A1 | Novel Piperidine Derivative | MSD K.K. (JP) | 2009-05-28 | — | — | US | claimed |
| US-8138206-B2 | Piperidine derivative | MSD. K.K. (JP) | 2012-03-20 | — | — | US | disclosed |
| US-20090137576-A1 | Novel Piperidine Derivative | MSD K.K. (JP) | 2009-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090137576-A1 | Novel Piperidine Derivative | HRH4, HRH3, HRH1 | HRH3 2/4885KCNH2 308/4885MAOB 1314/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.